Table 4.
MO | SC | UA | PD | AD | ‘33333’/ ‘55555’ |
|
---|---|---|---|---|---|---|
Floor | ||||||
Range of floor effects for the 3L (%) | 0–3.8 | 0–4.9 | 0–10.9 | 0–26.1 | 0–7.3 | 0–2.7 |
Range of floor effects for the 5L (%) | 0–3.0 | 0–3.7 | 0–6.5 | 0–5.7 | 0–2.5 | 0–1.8 |
Range of absolute reduction in floor effects (percentage points) | −0.9 to 1.7 | −0.3 to 1.2 | −1.7 to 6.3 | 0–20.4 | 0–4.8 | 0–0.9 |
Mean absolute reduction in floor effects (percentage points) | 0.14 | 0.25 | 1.43 | 4.29 | 1.64 | 0.21 |
Number of studies reporting on floor effects | 18 | 18 | 18 | 18 | 18 | 5 |
Number of studies reporting lower floor effects for the 5L than for the 3L | 7 | 6 | 13 | 16 | 14 | 3 |
MO | SC | UA | PD | AD | ‘11111’ | |
---|---|---|---|---|---|---|
Ceiling | ||||||
Range of ceiling effects for the 3L (%) | 10.2–97.7 | 61.4–99.5 | 10.8–94.8 | 2.3–80.3 | 24.5–88.0 | 0.6–68.0 |
Range of ceiling effects for the 5L (%) | 4.0–96.5 | 60.2–99.5 | 9.1–93.1 | 0.6–71.2 | 17.9–82.0 | 0–55.0 |
Range of absolute reduction in ceiling effects (percentage points) | −0.25 to 16.9 | −1.3 to 30.0 | 0.8–21.3 | 1.5–20.0 | −3.4 to 19.7 | −0.5 to 16.7 |
Mean absolute reduction in ceiling effects (percentage points) | 5.73 | 4.15 | 4.88 | 6.77 | 6.17 | 6.50 |
Number of studies reporting on ceiling effects | 20 | 20 | 20 | 20 | 20 | 22 |
Number of studies reporting lower ceiling effects for the 5L than for the 3L | 19 | 16 | 20 | 20 | 18 | 19 |
Number of studies reporting <15% ceiling for the 3L/5L | 1/2 | 0/0 | 1/2 | 3/3 | 0/0 | 7/8 |
The absolute reduction in floor effects was calculated by subtracting the number or percentage of the reported highest level of problems/‘55555’ for the 5L by the number or percentage of the reported highest level of problems/‘33333’ for the 3L, respectively. The absolute reduction in ceiling effects was calculated by subtracting the number or percentage of reported ‘no problems’/‘11111’ for the 5L by the number or percentage of reported ‘no problems’/‘11111’ for the 3L, respectively
MO Mobility, SC Self-Care, UA Usual Activities, PD Pain/Discomfort, AD Anxiety/Depression